Skip to main content

SNDL Inc.

SNDL
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001766600

No open-market purchases or sales by SNDL Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding SNDL Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of SNDL: Q1 2023 compared with Q2 2023
MeasureQ1 2023Of which not filed for Q2 2023Q2 2023Change
Holders1071100−6
Shares17.1M7.22M9.95M+14.4K (+0.1%)
Value$27.4M$11.5M$13.6M−$2.27M (−14.3%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (16)

Institutions that held SNDL Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to SNDL in Q2 2023
InstitutionSharesValue% of portfolio
GTS Securities LLC129,892$178.0K0.01%
Verition Fund Management LLC71,500$98.0K0.00%
Goldman Sachs Group Inc52,555$72.0K0.00%
Two Sigma Securities, LLC34,213$46.9K0.00%
Hilton Capital Management, LLC24,634$33.7K0.00%
Flow Traders U.S. LLC14,035$19.0K0.00%
CoreCap Advisors, LLC13,758$18.8K0.00%
First Capital Advisors Group, LLC.1,287$1.76K0.00%
Deutsche Bank AG460$6300.00%
O'Dell Group, LLC320$4390.00%
VisionPoint Advisory Group, LLC225$3080.00%
The PNC Financial Services Group, Inc.158$2160.00%
Fifth Third Bancorp100$1370.00%
IFP Advisors, Inc20$460.00%
Fiduciary Alliance LLC10$140.00%
City Holding Co7$90.00%

Sold out (22)

Institutions that held SNDL Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Not filed for Q2 2023 yet (1)

Institutions that held SNDL Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SNDL in Q1 2023 that haven't filed for Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
ETF Managers Group, LLC7,217,582$11.5M